Stock listing
Onconetix, Inc.
Selected listing: ONCO · NASDAQ · USD · US
Onconetix, Inc. (NASDAQ:ONCO), Health Technology. Latest release Sep 16, 2026: OncoC4 Receives FDA Fast Track Designation for Cesalatamig, an Investigational…
- Ticker
- NASDAQ:ONCO
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Onconetix, Inc.
Onconetix, Inc. (ONCO) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.
Latest news from Onconetix, Inc.
OncoC4 Receives FDA Fast Track Designation for Cesalatamig, an Investigational PD-1/VEGF Bispecific Antibody
September 16, 2026
CORRECTED: Onconetix Provides Strategic Bridge Financing to Realbotix LLC in Support of Pending Acquisition
September 14, 2026
Onconetix Provides Strategic Bridge Financing to Realbotix LLC in Support of Pending Acquisition
September 14, 2026
Onco360® Has Been Selected as Part of an Ultra-Narrow Specialty Pharmacy Network for MIMRYLO™ (rusfertide)
September 9, 2026
Onconetix Acquisition Target Realbotix Launches Pilot with Leading European Telecommunications Company to Deploy Humanoid Robots in Live Presentations and Events
September 3, 2026
Research Onconetix, Inc.
Alternate listings
ONCO:BOATS
US · USD
Alternate listing for Onconetix, Inc.; the primary context on this page is ONCO:NASDAQ.
J4T0:SWB
DE · EUR
Alternate listing for Onconetix, Inc.; the primary context on this page is ONCO:NASDAQ.
A426MU:GETTEX
DE · EUR
Alternate listing for Onconetix, Inc.; the primary context on this page is ONCO:NASDAQ.
J4T:FWB
DE · EUR
Alternate listing for Onconetix, Inc.; the primary context on this page is ONCO:NASDAQ.